Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
beta-hydroxy-beta-methylbutyrate + vitamin d
- Development stage
- Unknown
- Lead developer
- Metabolic Technologies Inc.
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
myHMB + Vitamin D is a combination nutritional supplement developed by Metabolic Technologies Inc. consisting of calcium beta-hydroxy-beta-methylbutyrate (HMB) and vitamin D3 (cholecalciferol). HMB, a metabolite of the essential amino acid leucine, promotes muscle health by stimulating protein synthesis through the mTOR pathway and reducing protein breakdown via the ubiquitin-proteasome system. Vitamin D3 is included to optimize muscle function and bone health, particularly in older adults where vitamin D insufficiency is prevalent. The combination is primarily investigated for its ability to enhance muscular strength, increase lean muscle mass, and improve physical functionality in elderly populations, especially when combined with resistance exercise.
- Brand names
- myHMB + Vitamin D
- Other names
- beta-hydroxy-beta-methylbutyrate + vitamin d-Metabolic Technologies Inc.HMB + Vitamin Dcalcium HMB + vitamin D3beta-hydroxy-beta-methylbutyrate + cholecalciferol
02
Targets
VDR (Vitamin D receptor)
Beyond the preview
Go deeper on beta-hydroxy-beta-methylbutyrate + vitamin d.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on beta-hydroxy-beta-methylbutyrate + vitamin d.